Role of OSCAR Signaling in Osteoclastogenesis and Bone Disease

Iva Nedeva, Mattia Vitale, Ari Elson, Judith Hoyland, Jordi Bella

Research output: Contribution to journalArticlepeer-review

64 Downloads (Pure)

Abstract

Formation of mature bone-resorbing cells through osteoclastogenesis is required for the continuous remodeling and repair of bone tissue. In aging and disease this process may become aberrant, resulting in excessive bone degradation and fragility fractures. Interaction of receptor-activator of nuclear factor-κB (RANK) with its ligand RANKL activates the main signaling pathway for osteoclastogenesis. However, compelling evidence indicates that this pathway may not be sufficient for the production of mature osteoclast cells and that co-stimulatory signals may be required for both the expression of osteoclast-specific genes and the activation of osteoclasts. Osteoclast-associated receptor (OSCAR), a regulator of osteoclast differentiation, provides one such co-stimulatory pathway. This review summarizes our present knowledge of osteoclastogenesis signaling and the role of OSCAR in the normal production of bone-resorbing cells and in bone disease. Understanding the signaling mechanism through this receptor and how it contributes to the production of mature osteoclasts may offer a more specific and targeted approach for pharmacological intervention against pathological bone resorption.
Original languageEnglish
Article number641162
JournalFront Cell Dev Biol
Volume9
DOIs
Publication statusPublished - 12 Apr 2021

Keywords

  • OSCAR
  • bone disease
  • bone remodeling
  • cell signaling
  • collagen
  • osteoclast-associated receptor
  • osteoclastogenesis

Fingerprint

Dive into the research topics of 'Role of OSCAR Signaling in Osteoclastogenesis and Bone Disease'. Together they form a unique fingerprint.

Cite this